Modvat credit for disposable syringes and needles packed with injections upheld where their value formed part of assessable value.

Modvat credit on disposable syringes and needles packed with injections was held admissible because the value of those items was included in the assessable value of the final product. The Revenue had treated the packing and inclusion of the unipack contents as part of the manufacturing process under Chapter Note V of Chapter 30, so the same goods could not be recognised for duty valuation and simultaneously excluded for credit purposes. Earlier decisions in the same assessee's case were distinguished on the basis that they concerned credit claimed as packing material on different facts. Denial of credit was therefore unsustainable.

---

---

Issues: Whether Modvat credit was admissible on disposable syringes and needles packed with injections and whether the Revenue could deny such credit when the value of those items was included in the assessable value of the final product.

Analysis: The dispute turned on the nature of the goods and the treatment adopted by the Revenue. The appellants had cleared the injections in unipacks with disposable syringes and needles, and the value of those items was included in the assessable value. The Revenue itself treated the packing and treatment of the medicines as part of the manufacturing process under Chapter Note V of Chapter 30. In that situation, the same goods could not be treated as relevant for duty valuation and yet be excluded for credit purposes. The earlier decisions in the appellants' own case were distinguished because they proceeded on a different factual basis, namely, credit claimed as packing material.

Conclusion: Modvat credit on disposable syringes and needles was admissible, and denial of credit was unsustainable.

---